Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial
The Lancet. Haematology, 2019-09 [Peer Reviewed Journal]info:eu-repo/semantics/openAccess ;ISSN: 2352-3026 ;EISSN: 2352-3026 ;DOI: 10.1016/S2352-3026(19)30110-3
Digital Resources/Online E-Resources
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||